37
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1573-1582 | Received 15 Jan 2024, Accepted 03 May 2024, Published online: 16 May 2024